Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus

David C. Montefiori, Jiying Zhou, Brenda Barnes, Douglas Lake, Evan M Hersh, Yasuhiko Masuho, Lewis B. Lefkowitz

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Human immunodeficiency virus type 1 (HIV-1) exhibits extensive genomic and antigenic diversity, which is thought to contribute to the failure of the host's immune response to control infection and prevent clinical progression. Part of this failure may be due to utilization by the virus of antigenic variation as a means to escape protective immune responses. Antibody-escape variants of HIV-1 were studied here using fresh clinical isolates and autologous plasmas. HIV-1 was isolated from the plasma of seven people who were all seropositive for at least 2 years, and symptomatic sometime during that period. Isolated viruses were confirmed as HIV-1 by the presence of reverse transcriptase activity in infected culture supernatants, and by positive immunofluorescence using human monoclonal antibody to HIV-1 core protein. Plasma from these people were positive by Western immunoblot (DuPont) for most major HIV-1 (strain IIIB) antigens. These plasmas neutralized three laboratory strains of HIV-1 (i.e., IIIB, RF, and MN) but did not neutralize the homotypic strain in five cases, and had greatly reduced neutralizing titers against the homotypic strain in two cases. Homotypic neutralizing antibodies were absent in autologous plasma obtained 3 months later. When antibody titers were measured by fixed-cell indirect immunofluorescence assays (IFAs), high titers of IgG (1:6400 to 1:25,600) were detected against HIV-1 IIIB, while low titers of only 1:20 to 1:160 were detected against homotypic viral antigens at the time of virus isolation, and remained low 12 and 16 weeks later. No class IgA, IgD, IgE, or IgM antibodies to homotypic viral antigens, as possible IgG-blocking antibodies, were detected by fixed-cell IFAs. Cross-reactions with heterologous donor's plasmas were observed in some cases, and in these cases the cross-reactions were unidirectional. Live-cell IFAs detected IgG in patient's plasma to HIV-1 IIIB-infected cells but not to cells infected with homotypic isolates. These results suggest that it is common for neutralization-resistant HIV-1 variants to appear during the course of infection, and that all or most antigens of these variants are capable of escaping antibody recognition.

Original languageEnglish (US)
Pages (from-to)635-643
Number of pages9
JournalVirology
Volume182
Issue number2
DOIs
StatePublished - 1991

Fingerprint

Antibody Formation
HIV-1
HIV
Fluorescent Antibody Technique
Antigenic Variation
Viral Antigens
Antibodies
Immunoglobulin G
Cross Reactions
Viruses
Viral Core Proteins
Antigens
Immunoglobulin D
Blocking Antibodies
Indirect Fluorescent Antibody Technique
Infection Control
Neutralizing Antibodies
Immunoglobulin A
Immunoglobulin E
Immunoglobulin M

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Montefiori, D. C., Zhou, J., Barnes, B., Lake, D., Hersh, E. M., Masuho, Y., & Lefkowitz, L. B. (1991). Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus. Virology, 182(2), 635-643. https://doi.org/10.1016/0042-6822(91)90604-A

Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus. / Montefiori, David C.; Zhou, Jiying; Barnes, Brenda; Lake, Douglas; Hersh, Evan M; Masuho, Yasuhiko; Lefkowitz, Lewis B.

In: Virology, Vol. 182, No. 2, 1991, p. 635-643.

Research output: Contribution to journalArticle

Montefiori, DC, Zhou, J, Barnes, B, Lake, D, Hersh, EM, Masuho, Y & Lefkowitz, LB 1991, 'Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus', Virology, vol. 182, no. 2, pp. 635-643. https://doi.org/10.1016/0042-6822(91)90604-A
Montefiori, David C. ; Zhou, Jiying ; Barnes, Brenda ; Lake, Douglas ; Hersh, Evan M ; Masuho, Yasuhiko ; Lefkowitz, Lewis B. / Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus. In: Virology. 1991 ; Vol. 182, No. 2. pp. 635-643.
@article{d42ddd43f6e3442dbfac4d25fd367eca,
title = "Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus",
abstract = "Human immunodeficiency virus type 1 (HIV-1) exhibits extensive genomic and antigenic diversity, which is thought to contribute to the failure of the host's immune response to control infection and prevent clinical progression. Part of this failure may be due to utilization by the virus of antigenic variation as a means to escape protective immune responses. Antibody-escape variants of HIV-1 were studied here using fresh clinical isolates and autologous plasmas. HIV-1 was isolated from the plasma of seven people who were all seropositive for at least 2 years, and symptomatic sometime during that period. Isolated viruses were confirmed as HIV-1 by the presence of reverse transcriptase activity in infected culture supernatants, and by positive immunofluorescence using human monoclonal antibody to HIV-1 core protein. Plasma from these people were positive by Western immunoblot (DuPont) for most major HIV-1 (strain IIIB) antigens. These plasmas neutralized three laboratory strains of HIV-1 (i.e., IIIB, RF, and MN) but did not neutralize the homotypic strain in five cases, and had greatly reduced neutralizing titers against the homotypic strain in two cases. Homotypic neutralizing antibodies were absent in autologous plasma obtained 3 months later. When antibody titers were measured by fixed-cell indirect immunofluorescence assays (IFAs), high titers of IgG (1:6400 to 1:25,600) were detected against HIV-1 IIIB, while low titers of only 1:20 to 1:160 were detected against homotypic viral antigens at the time of virus isolation, and remained low 12 and 16 weeks later. No class IgA, IgD, IgE, or IgM antibodies to homotypic viral antigens, as possible IgG-blocking antibodies, were detected by fixed-cell IFAs. Cross-reactions with heterologous donor's plasmas were observed in some cases, and in these cases the cross-reactions were unidirectional. Live-cell IFAs detected IgG in patient's plasma to HIV-1 IIIB-infected cells but not to cells infected with homotypic isolates. These results suggest that it is common for neutralization-resistant HIV-1 variants to appear during the course of infection, and that all or most antigens of these variants are capable of escaping antibody recognition.",
author = "Montefiori, {David C.} and Jiying Zhou and Brenda Barnes and Douglas Lake and Hersh, {Evan M} and Yasuhiko Masuho and Lefkowitz, {Lewis B.}",
year = "1991",
doi = "10.1016/0042-6822(91)90604-A",
language = "English (US)",
volume = "182",
pages = "635--643",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus

AU - Montefiori, David C.

AU - Zhou, Jiying

AU - Barnes, Brenda

AU - Lake, Douglas

AU - Hersh, Evan M

AU - Masuho, Yasuhiko

AU - Lefkowitz, Lewis B.

PY - 1991

Y1 - 1991

N2 - Human immunodeficiency virus type 1 (HIV-1) exhibits extensive genomic and antigenic diversity, which is thought to contribute to the failure of the host's immune response to control infection and prevent clinical progression. Part of this failure may be due to utilization by the virus of antigenic variation as a means to escape protective immune responses. Antibody-escape variants of HIV-1 were studied here using fresh clinical isolates and autologous plasmas. HIV-1 was isolated from the plasma of seven people who were all seropositive for at least 2 years, and symptomatic sometime during that period. Isolated viruses were confirmed as HIV-1 by the presence of reverse transcriptase activity in infected culture supernatants, and by positive immunofluorescence using human monoclonal antibody to HIV-1 core protein. Plasma from these people were positive by Western immunoblot (DuPont) for most major HIV-1 (strain IIIB) antigens. These plasmas neutralized three laboratory strains of HIV-1 (i.e., IIIB, RF, and MN) but did not neutralize the homotypic strain in five cases, and had greatly reduced neutralizing titers against the homotypic strain in two cases. Homotypic neutralizing antibodies were absent in autologous plasma obtained 3 months later. When antibody titers were measured by fixed-cell indirect immunofluorescence assays (IFAs), high titers of IgG (1:6400 to 1:25,600) were detected against HIV-1 IIIB, while low titers of only 1:20 to 1:160 were detected against homotypic viral antigens at the time of virus isolation, and remained low 12 and 16 weeks later. No class IgA, IgD, IgE, or IgM antibodies to homotypic viral antigens, as possible IgG-blocking antibodies, were detected by fixed-cell IFAs. Cross-reactions with heterologous donor's plasmas were observed in some cases, and in these cases the cross-reactions were unidirectional. Live-cell IFAs detected IgG in patient's plasma to HIV-1 IIIB-infected cells but not to cells infected with homotypic isolates. These results suggest that it is common for neutralization-resistant HIV-1 variants to appear during the course of infection, and that all or most antigens of these variants are capable of escaping antibody recognition.

AB - Human immunodeficiency virus type 1 (HIV-1) exhibits extensive genomic and antigenic diversity, which is thought to contribute to the failure of the host's immune response to control infection and prevent clinical progression. Part of this failure may be due to utilization by the virus of antigenic variation as a means to escape protective immune responses. Antibody-escape variants of HIV-1 were studied here using fresh clinical isolates and autologous plasmas. HIV-1 was isolated from the plasma of seven people who were all seropositive for at least 2 years, and symptomatic sometime during that period. Isolated viruses were confirmed as HIV-1 by the presence of reverse transcriptase activity in infected culture supernatants, and by positive immunofluorescence using human monoclonal antibody to HIV-1 core protein. Plasma from these people were positive by Western immunoblot (DuPont) for most major HIV-1 (strain IIIB) antigens. These plasmas neutralized three laboratory strains of HIV-1 (i.e., IIIB, RF, and MN) but did not neutralize the homotypic strain in five cases, and had greatly reduced neutralizing titers against the homotypic strain in two cases. Homotypic neutralizing antibodies were absent in autologous plasma obtained 3 months later. When antibody titers were measured by fixed-cell indirect immunofluorescence assays (IFAs), high titers of IgG (1:6400 to 1:25,600) were detected against HIV-1 IIIB, while low titers of only 1:20 to 1:160 were detected against homotypic viral antigens at the time of virus isolation, and remained low 12 and 16 weeks later. No class IgA, IgD, IgE, or IgM antibodies to homotypic viral antigens, as possible IgG-blocking antibodies, were detected by fixed-cell IFAs. Cross-reactions with heterologous donor's plasmas were observed in some cases, and in these cases the cross-reactions were unidirectional. Live-cell IFAs detected IgG in patient's plasma to HIV-1 IIIB-infected cells but not to cells infected with homotypic isolates. These results suggest that it is common for neutralization-resistant HIV-1 variants to appear during the course of infection, and that all or most antigens of these variants are capable of escaping antibody recognition.

UR - http://www.scopus.com/inward/record.url?scp=0025854294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025854294&partnerID=8YFLogxK

U2 - 10.1016/0042-6822(91)90604-A

DO - 10.1016/0042-6822(91)90604-A

M3 - Article

C2 - 1708933

AN - SCOPUS:0025854294

VL - 182

SP - 635

EP - 643

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -